HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.

Abstract
The epothilones are naturally occurring, cytotoxic macrolides that function through a paclitaxel (Taxol)-like mechanism. Although structurally dissimilar, both classes of molecules lead to the arrest of cell division and eventual cell death by stabilizing cellular microtubule assemblies. The epothilones differ in their ability to retain activity against multidrug-resistant (MDR) cell lines and tumors where paclitaxel fails. In the current account, we focus on the relationship between epothilone and paclitaxel in the context of tumors with multiple drug resistance. The epothilone analogue Z-12,13-desoxyepothilone B (dEpoB) is >35,000-fold more potent than paclitaxel in inhibiting cell growth in the MDR DC-3F/ADX cell line. Various formulations, routes, and schedules of i.v. administration of dEpoB have been tested in nude mice. Slow infusion with a Cremophor-ethanol vehicle proved to be the most beneficial in increasing efficacy and decreasing toxicity. Although dEpoB performed similarly to paclitaxel in sensitive tumors xenografts (MX-1 human mammary and HT-29 colon tumor), its effects were clearly superior against MDR tumors. When dEpoB was administered to nude mice bearing our MDR human lymphoblastic T cell leukemia (CCRF-CEM/paclitaxel), dEpoB demonstrated a full curative effect. For human mammary adenocarcinoma MCF-7/Adr cells refractory to paclitaxel, dEpoB reduced the established tumors, markedly suppressed tumor growth, and surpassed other commonly used chemotherapy drugs such as adriamycin, vinblastine, and etoposide in beneficial effects.
AuthorsT C Chou, X G Zhang, C R Harris, S D Kuduk, A Balog, K A Savin, J R Bertino, S J Danishefsky
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 95 Issue 26 Pg. 15798-802 (Dec 22 1998) ISSN: 0027-8424 [Print] United States
PMID9861050 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Epothilones
  • Lactones
  • Thiazoles
  • Paclitaxel
  • desoxyepothilone B
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use, toxicity)
  • Breast Neoplasms (drug therapy)
  • Cell Survival (drug effects)
  • Drug Resistance, Neoplasm
  • Epothilones
  • Female
  • Humans
  • Lactones (therapeutic use, toxicity)
  • Leukemia P388
  • Leukemia-Lymphoma, Adult T-Cell
  • Mice
  • Mice, Nude
  • Ovarian Neoplasms (drug therapy)
  • Paclitaxel (therapeutic use, toxicity)
  • Structure-Activity Relationship
  • Thiazoles (therapeutic use, toxicity)
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: